Over the last 180 days, Kalaris Therapeutics, Inc. insiders bought a net $1.2M of stock across 4 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-46.2M | $-51.7M | $-199.9M | $-171.2M |
| NET INCOME | $-43.4M | $-69.2M | $-190.4M | $-168.7M |
| EPS (DILUTED) | -2.85 | -51.77 | -42.09 | -2.20 |
| OPERATING CASH FLOW | $-38.4M | $-20.7M | $-124.5M | $-142.1M |
| CASH | $98.1M | $1.6M | $90.1M | $106.1M |
No password to create and no card required. We store your email address and nothing else.